dc.contributor.author |
Großmann, Klaus |
|
dc.date.accessioned |
2023-09-26T09:48:19Z |
|
dc.date.available |
2023-09-26T09:48:19Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
2227-9059 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/145931 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Mdpi |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3390/biomedicines10081890 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230202000000_02013 |
|
utue.personen.roh |
Grossmann, Klaus |
|
dcterms.isPartOf.ZSTitelID |
Biomedicines |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 1890 |
de_DE |
dcterms.isPartOf.ZS-Volume |
10 (8) |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |